Results from the Solithromycin International Surveillance Program (2014).
In conclusion, solithromycin demonstrated potent activity against global and contemporary (2014) pathogens that represent the major causes of community-acquired bacterial pneumonia. These data support the continued clinical development of solithromycin for the treatment of this important indication.
PMID: 27044551 [PubMed - as supplied by publisher]
Source: Antimicrobial Agents and Chemotherapy - Category: Microbiology Authors: Farrell DJ, Flamm RK, Sader HS, Jones RN Tags: Antimicrob Agents Chemother Source Type: research
More News: Azithromycin | Bacterial Pneumonia | Chemotherapy | Haemophilus Influenzae (Hib) | Ketek | Microbiology | MRSA | Pneumonia | Staphylococcus Aureus | Telithromycin | Zithromax